CHINARES PHARMA (03320): China Resources Boya Bio-pharmaceutical Group's net profit in the first quarter was 30.0333 million yuan, a year-on-year decrease of 78.4%.
China Resources Pharmaceutical (03320) announced that its subsidiary China Resources BoYa Biopharmaceutical Group Co., Ltd. (China Resources BoYa Biopharmaceutical) achieved total operating income of 321 million yuan in the three months ending March 31, 2026, a year-on-year decrease of 40.1%; net profit was 30.0333 million yuan, down 78.4% year-on-year.
CHINARES PHARMA (03320) announced that its subsidiary, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (China Resources Boya Bio-pharmaceutical Group), achieved a total operating income of 321 million yuan and a net profit of 30.33 million yuan for the three months ending on March 31, 2026, representing a decrease of 40.1% and 78.4% year-on-year, respectively.
Related Articles
.png)
NETEASE MUSIC (09899) spent 14.9979 million Hong Kong dollars on April 24 to repurchase 126,900 shares.
Ping An Insurance (02318): Ping An Bank's net profit for the first quarter was 14.523 billion yuan, a year-on-year increase of 3%.
EASOU TECH (02550) subscribes to wealth management products according to the subscription plan.
NETEASE MUSIC (09899) spent 14.9979 million Hong Kong dollars on April 24 to repurchase 126,900 shares.
Ping An Insurance (02318): Ping An Bank's net profit for the first quarter was 14.523 billion yuan, a year-on-year increase of 3%.
EASOU TECH (02550) subscribes to wealth management products according to the subscription plan.
RECOMMEND
The Great Transformation Of The Hong Kong Automotive Market
23/04/2026
Another “Elephant” Dances As China Construction Bank Hits A Record High While The Sector Remains Below Book Value, With Several Names Offering Elevated Dividend Yields
23/04/2026
Major Oil Traders Warn One Billion Barrel Shortfall Is Locked In, Hormuz Closure Could Trigger Recession
23/04/2026
